Exploring prognostic and predictive response therapy factors in cancer disease is one of the most exciting issues of modern oncological science. Targeting intracellular signalling molecules is one of the novel approaches in which basic and translational researches meet clinical practice to define the best management of malignancies. The goal for target therapies is to identify agents that target tumor-specific molecules, thus sparing normal tissues. Those molecules are called biomarkers, and their identification is recommended for correct therapeutic planning. Hence, the contribution of clinical and surgical pathology to define cancer prognostic groups and treatment responsive tumors is essential not only for the efficacy of the cures, but also for ethical, economical, and social reasons. The promises of tailored (personalized) therapy are now almost certainly realistic and can give concrete hope to many cancer patients in the world. In this book, we have tried to describe the "state of art" in these fields of oncology, specifically considering prognostic and predictive response therapy factors in colorectal, breast, lung, gastric, renal, liver and prostate cancers.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Dr Massimiliano Berretta, born in 1972 graduated from Medical School at the University of Catania, Italy, in 1996. He achieved his Specialty Degree in Oncology in 2001, and in Geriatrics and Gerontology in 2009, at the same University. He works as assistant at the Division of Medical Oncology A, Department of Medical Oncology, National Cancer Institute of Aviano since 2004. Since October 2005 is a visiting professor at the PhD in "multimodal approach oncology geriatric" at the University of Catania. Since November 2013 he is a member of the "Euro-Mediterranean Institute of Science and Technology" (IEMEST), Palermo; From May 2011 he joined the Board of Directors of Multidisciplinary Studies in Oncology (ASMO); From March 2009, he is a member of the Italian Association of Thoracic Oncology (AIOT); From January 2008 he is member of the Italian Germ Cell Cancer Group (IGG); From April 2006 is member of the Italian Association of Medical Oncology (AIOM); From January 2006 he is member of the American Society of Clinical Oncology (ASCO); Since November 2002 he is member of the Italian Cooperative Group Aids and Cancer (Gicat); Since October 1999 he is a member of the Italian Sarcoma Group.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Romtrade Corp., STERLING HEIGHTS, MI, USA
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. Artikel-Nr. ABBB-121522
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Zustand: Used. Artikel-Nr. 311927787
Anzahl: 1 verfügbar
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: Used. Artikel-Nr. 18316677182
Anzahl: 1 verfügbar
Anbieter: Kennys Bookstore, Olney, MD, USA
Zustand: New. Editor(s): Canzonieri, Vincenzo; Berretta, Massimiliano. Num Pages: 140 pages. BIC Classification: MJCL. Category: (P) Professional & Vocational. Dimension: 236 x 157 x 17. Weight in Grams: 402. . 2015. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland. Artikel-Nr. V9781634635455
Anzahl: 1 verfügbar
Anbieter: moluna, Greven, Deutschland
Gebunden. Zustand: New. Artikel-Nr. 31399365
Anzahl: 1 verfügbar
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Neuware. Artikel-Nr. 9781634635455
Anzahl: 1 verfügbar
Anbieter: BOOKIT!, Genève, Schweiz
Zustand: Used: Like New. LIVRE A L?ETAT DE NEUF. EXPEDIE SOUS 3 JOURS OUVRES. NUMERO DE SUIVI COMMUNIQUE AVANT ENVOI, EMBALLAGE RENFORCE. EAN:9781634635455. Artikel-Nr. SLIVCN-9781634635455
Anzahl: 1 verfügbar